the competition in retail is formidable. Sigma Aldrich was bought by EMD Millipore, the US arm of Germany's Merck. I think they are the standard, if you are writing serious white papers. SA has history and reputation. I see that Sigma Millipore may be branching into joint research with universities in the biomedical field. Biomedical has a long development arc because of govt regulations but an advantage is the chance for high returns, and that each unit of product uses very small amounts of QD.

QMC would find it hard to compete in their market. But we are going after a different market. Our best retail market are the small startups and incubators with products ready to commercialize.